Year archive

Novo Nordisk — 2022 filings

All 285 regulatory filings released by Novo Nordisk (NOVO) in 2022, sourced directly from the official regulator.

285 Filings

2022 Period

2022 filings (285)

Filing	Released	Lang
FORM 6-K Regulatory Filings	2022-12-22	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-12-22	English
Novo Nordisk A/S: Transaction in Own Shares	2022-12-22	Danish
Novo Nordisk A/S: Transaction in Own Shares	2022-12-22	English
FORM 6-K Regulatory Filings	2022-12-20	English
FORM 6-K Regulatory Filings	2022-12-20	English
Director's Dealing 2022 Director's Dealing	2022-12-19	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-12-19	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-12-19	Danish
Transaction in Own Shares 2022 Transaction in Own Shares	2022-12-12	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-12-12	Danish
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-12-12	Danish
FORM 6-K Regulatory Filings	2022-12-05	English
FORM 6-K Regulatory Filings	2022-12-05	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-12-05	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-12-05	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-12-05	Danish
Director's Dealing 2022 Director's Dealing	2022-11-30	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-11-30	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-11-30	Danish
FORM 6-K Regulatory Filings	2022-11-21	English
Director's Dealing 2022 Director's Dealing	2022-11-21	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-11-21	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-11-21	Danish
FORM 6-K Regulatory Filings	2022-11-15	English
Director's Dealing 2022 Director's Dealing	2022-11-15	English
Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2022-11-15	Danish
FORM 6-K Regulatory Filings	2022-11-14	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-11-14	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-11-14	Danish
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-11-14	Danish
FORM 6-K Regulatory Filings	2022-11-14	English
FORM 6-K Regulatory Filings	2022-11-14	English
FORM 6-K Regulatory Filings	2022-11-14	English
FORM 6-K Regulatory Filings	2022-11-07	English
Director's Dealing 2022 Director's Dealing	2022-11-04	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2022-11-04	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-11-04	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-11-04	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-11-04	English
Novo Nordisk A/S purchases B shares worth DKK 3,582 million from Novo Holdings A/S under the 2022 share repurchase programme Transaction in Own Shares	2022-11-04	English
Director's Dealing 2022 Director's Dealing	2022-11-03	English
Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2022-11-03	English
6-K Regulatory Filings	2022-11-02	English
FORM 6-K Regulatory Filings	2022-11-01	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-11-01	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-11-01	English
FORM 6-K Regulatory Filings	2022-10-24	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-10-24	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-10-24	English
FORM 6-K Regulatory Filings	2022-10-17	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-10-17	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-10-17	English
SC TO-T/A Filing Regulatory Filings	2022-10-14	English
FORM 6-K Regulatory Filings	2022-10-11	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-10-10	English
Novo Nordisk A/S: Transaction in Own Shares	2022-10-10	English
SC TO-T/A Filing Regulatory Filings	2022-10-07	English
FORM 6-K Regulatory Filings	2022-10-06	English
FORM 6-K Regulatory Filings	2022-10-03	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-10-03	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-10-03	English
Earnings Release 2022 Earnings Release Q4 2022	2022-10-03	English
Once-weekly insulin icodec demonstrates superior reduction in HbA1c in combination with a dosing guide app versus once-daily basal insulin in people with type 2 diabetes in ONWARDS 5 phase 3a trial Regulatory Filings	2022-10-03	English
SC TO-T/A Filing Regulatory Filings	2022-09-28	English
FORM 6-K Regulatory Filings	2022-09-26	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-09-26	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-09-26	English
FORM 6-K Regulatory Filings	2022-09-19	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-09-19	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-09-19	English
SC TO-T Filing Regulatory Filings	2022-09-15	English
FORM 6-K Regulatory Filings	2022-09-13	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-09-12	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-09-12	Danish
FORM 6-K Regulatory Filings	2022-09-06	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-09-05	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-09-05	English
SC TO-C Filing Regulatory Filings	2022-09-01	English
FORM 6-K Regulatory Filings	2022-08-29	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-08-29	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-08-29	Danish
FORM 6-K Regulatory Filings	2022-08-22	English
FORM 6-K Regulatory Filings	2022-08-22	English
FORM 6-K Regulatory Filings	2022-08-22	English
FORM 6-K Regulatory Filings	2022-08-22	English
FORM 6-K Regulatory Filings	2022-08-22	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-08-22	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-08-22	Danish
Regulatory Filings 2022 Regulatory Filings	2022-08-22	English
Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes Regulatory Filings	2022-08-22	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-08-15	English
Novo Nordisk A/S: Share repurchase programme Transaction in Own Shares	2022-08-15	Danish
Director's Dealing 2022 Director's Dealing	2022-08-08	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2022-08-08	English
Director's Dealing 2022 Director's Dealing	2022-08-05	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2022-08-05	English
6-K Regulatory Filings	2022-08-03	English
Earnings Release 2022 Earnings Release H1 2022	2022-08-03	English
Novo Nordisk's sales increased by 25% in Danish kroner and by 16% at constant exchange rates to DKK 83.3 billion in the first six months of 2022 Interim / Quarterly Report H1 2022	2022-08-03	English
Earnings Release 2022 Earnings Release H1 2022	2022-08-03	English
Novo Nordisk's sales increased by 25% in Danish kroner and by 16% at constant exchange rates to DKK 83.3 billion in the first six months of 2022 Interim / Quarterly Report H1 2022	2022-08-03	English
FORM 6-K Regulatory Filings	2022-08-03	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-08-03	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-08-03	English
FORM 6-K Regulatory Filings	2022-07-29	English
Regulatory Filings 2022 Regulatory Filings	2022-07-29	English
Novo Nordisk achieves primary objectives of ONWARDS 3 and 4 trials with once-weekly insulin icodec demonstrating superior reduction in HbA1c vs insulin degludec in ONWARDS 3 Regulatory Filings	2022-07-29	English
FORM 6-K Regulatory Filings	2022-07-25	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-07-25	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-07-25	Danish
FORM 6-K Regulatory Filings	2022-07-18	English
FORM 6-K Regulatory Filings	2022-07-18	English
FORM 6-K Regulatory Filings	2022-07-18	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-07-18	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-07-18	Danish
Transaction in Own Shares 2022 Transaction in Own Shares	2022-07-11	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-07-11	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-07-04	English
Novo Nordisk A/S: Share repurchase programme Transaction in Own Shares	2022-07-04	English
Regulatory Filings 2022 Regulatory Filings	2022-06-29	English
Regulatory Filings 2022 Regulatory Filings	2022-06-29	English
FORM 6-K Regulatory Filings	2022-06-27	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-06-27	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-06-27	English
FORM 6-K Regulatory Filings	2022-06-21	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-06-20	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-06-20	English
FORM 6-K Regulatory Filings	2022-06-13	English
FORM 6-K Regulatory Filings	2022-06-13	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-06-13	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-06-13	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-06-07	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-06-07	English
FORM 6-K Regulatory Filings	2022-06-07	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-06-07	English
Novo Nordisk A/S: Major Shareholding Notification	2022-06-07	English
FORM 6-K Regulatory Filings	2022-06-03	English
Regulatory Filings 2022 Regulatory Filings	2022-06-03	English
Novo Nordisk achieves primary objectives of ONWARDS 1 and 6 trials with once-weekly insulin icodec demonstrating superior reduction in HbA1c vs insulin glargine U100 in ONWARDS 1 Regulatory Filings	2022-06-03	English
FORM SD Regulatory Filings	2022-05-31	English
FORM 6-K Regulatory Filings	2022-05-31	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-05-30	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-05-30	English
FORM 6-K Regulatory Filings	2022-05-24	English
FORM 6-K Regulatory Filings	2022-05-24	English
FORM 6-K Regulatory Filings	2022-05-24	English
FORM 6-K Regulatory Filings	2022-05-23	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-05-23	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-05-23	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-05-16	English
Novo Nordisk A/S: Share repurchase programme Transaction in Own Shares	2022-05-16	English
Director's Dealing 2022 Director's Dealing	2022-05-11	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2022-05-11	English
FORM 6-K Regulatory Filings	2022-05-06	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-05-06	English
Novo Nordisk A/S: Major Shareholding Notification	2022-05-06	English
Director's Dealing 2022 Director's Dealing	2022-05-06	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2022-05-06	English
FORM 6-K Regulatory Filings	2022-05-04	English
FORM 6-K Regulatory Filings	2022-05-04	English
FORM 6-K Regulatory Filings	2022-05-04	English
FORM 6-K Regulatory Filings	2022-05-03	English
Director's Dealing 2022 Director's Dealing	2022-05-03	English
Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2022-05-03	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-05-03	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-05-03	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-05-03	English
Novo Nordisk A/S purchases B shares worth DKK 3,402 million from Novo Holdings A/S under the 2022 share repurchase programme Transaction in Own Shares	2022-05-03	English
Director's Dealing 2022 Director's Dealing	2022-05-03	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2022-05-03	English
FORM 6-K Regulatory Filings	2022-05-03	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-05-03	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-05-03	English
FORM 6-K Regulatory Filings	2022-05-03	English
FORM 6-K Regulatory Filings	2022-05-03	English
FORM 6-K Regulatory Filings	2022-05-03	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-05-02	English
Novo Nordisk – major shareholder announcement Major Shareholding Notification	2022-05-02	English
Director's Dealing 2022 Director's Dealing	2022-05-02	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 29 April 2022 Director's Dealing	2022-05-02	English
Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 29 April 2022 Declaration of Voting Results & Voting Rights Announcements	2022-04-29	English
Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 29 April 2022 Share Issue/Capital Change	2022-04-29	English
6-K Regulatory Filings	2022-04-29	English
Earnings Release 2022 Earnings Release Q1 2022	2022-04-29	English
Novo Nordisk's sales increased by 24% in Danish kroner and by 18% at constant exchange rates to DKK 42.0 billion in the first three months of 2022 Earnings Release Q1 2022	2022-04-29	English
FORM 6-K Regulatory Filings	2022-04-28	English
Earnings Release 2022 Earnings Release FY 2022	2022-04-28	English
Once-weekly insulin icodec demonstrates superior reduction in HbA1c vs insulin degludec in people with type 2 diabetes in ONWARDS 2 phase 3a trial Regulatory Filings	2022-04-28	English
FORM 6-K Regulatory Filings	2022-04-27	English
FORM 6-K Regulatory Filings	2022-04-27	English
Novo Nordisk A/S – Reduction of the share capital Share Issue/Capital Change	2022-04-27	English
Novo Nordisk A/S – Reduction of the share capital Share Issue/Capital Change	2022-04-27	English
FORM 6-K Regulatory Filings	2022-04-25	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-04-25	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-04-25	English
FORM 6-K Regulatory Filings	2022-04-11	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-04-11	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-04-11	Danish
FORM 6-K Regulatory Filings	2022-04-04	English
FORM 6-K Regulatory Filings	2022-04-04	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-04-04	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-04-04	Danish
FORM 6-K Regulatory Filings	2022-03-29	English
Earnings Release 2022 Earnings Release Q1 2022	2022-03-28	English
Ozempic® 2.0 mg approved in the US for the treatment of type 2 diabetes Regulatory Filings	2022-03-28	Danish
Transaction in Own Shares 2022 Transaction in Own Shares	2022-03-28	English
Novo Nordisk A/S: Share repurchase programme Transaction in Own Shares	2022-03-28	English
FORM 6-K Regulatory Filings	2022-03-24	English
FORM 6-K Regulatory Filings	2022-03-24	English
S-8 Regulatory Filings	2022-03-24	English
FORM 6-K Regulatory Filings	2022-03-22	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-03-21	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-03-21	English
FORM 6-K Regulatory Filings	2022-03-15	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-03-14	English
Novo Nordisk – major shareholder announcement Major Shareholding Notification	2022-03-14	English
FORM 6-K Regulatory Filings	2022-03-14	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-03-14	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-03-14	Danish
FORM 6-K Regulatory Filings	2022-03-07	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-03-07	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-03-07	Danish
FORM 6-K Regulatory Filings	2022-03-07	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-03-04	English
Novo Nordisk – major shareholder announcement Major Shareholding Notification	2022-03-04	Danish
FORM 6-K Regulatory Filings	2022-03-03	English
FORM 6-K Regulatory Filings	2022-03-01	English
FORM 6-K Regulatory Filings	2022-02-28	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-02-28	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-02-28	Danish
FORM 6-K Regulatory Filings	2022-02-22	English
FORM 6-K Regulatory Filings	2022-02-22	English
FORM 6-K Regulatory Filings	2022-02-22	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-02-21	English
Novo Nordisk – major shareholder announcement Major Shareholding Notification	2022-02-21	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-02-21	English
Novo Nordisk A/S: Share repurchase programme Transaction in Own Shares	2022-02-21	Danish
FORM 6-K Regulatory Filings	2022-02-15	English
FORM 6-K Regulatory Filings	2022-02-15	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-02-14	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-02-14	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-02-14	English
Novo Nordisk – major shareholder announcement Major Shareholding Notification	2022-02-14	English
FORM 6-K Regulatory Filings	2022-02-14	English
Director's Dealing 2022 Director's Dealing	2022-02-11	English
Trading in Novo Nordisk shares by board members, executives and associated persons on 8 February 2022 Director's Dealing	2022-02-11	English
FORM 6-K Regulatory Filings	2022-02-10	English
FORM 6-K Regulatory Filings	2022-02-10	English
Director's Dealing 2022 Director's Dealing	2022-02-09	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 4 February 2022 Director's Dealing	2022-02-09	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-02-07	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-02-07	English
Director's Dealing 2022 Director's Dealing	2022-02-04	English
IRANNOTICE Regulatory Filings	2022-02-02	English
20-F Annual Report FY 2021	2022-02-02	English
6-K Regulatory Filings	2022-02-02	English
6-K Regulatory Filings	2022-02-02	English
Novo Nordisk Annual Report 2021 Annual Report (ESEF) FY 2021	2022-02-02	English
Annual Report (ESEF) 2021 Annual Report (ESEF) FY 2021	2022-02-02	English
Earnings Release 2021 Earnings Release FY 2021	2022-02-02	English
Novo Nordisk's sales increased by 11% in Danish kroner and by 14% at constant exchange rates to DKK 140.8 billion in 2021 Annual Report FY 2021	2022-02-02	Danish
FORM 6-K Regulatory Filings	2022-02-01	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-02-01	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-02-01	English
FORM 6-K Regulatory Filings	2022-02-01	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-01-31	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-01-31	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-01-31	English
FORM 6-K Regulatory Filings	2022-01-25	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-01-24	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-01-24	English
FORM 6-K Regulatory Filings	2022-01-21	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-01-20	English
Legal Proceedings Report 2022 Legal Proceedings Report	2022-01-20	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-01-20	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-01-20	English
Regulatory Filings 2022 Regulatory Filings	2022-01-20	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-01-20	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-01-20	English
Novo Nordisk A/S: Share repurchase programme Transaction in Own Shares	2022-01-20	English
Director's Dealing 2022 Director's Dealing	2022-01-20	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2022-01-20	English
FORM 6-K Regulatory Filings	2022-01-18	English
FORM 6-K Regulatory Filings	2022-01-10	English

Filings by year

2026 118 filings
2025 119 filings
2024 357 filings
2023 312 filings
2022 285 filings
2021 239 filings
2020 244 filings
2019 293 filings
2018 549 filings
2017 465 filings
2016 479 filings
2015 274 filings
2014 254 filings
2013 295 filings
2012 320 filings
2011 316 filings
2010 296 filings
2009 204 filings
2008 164 filings
2007 21 filings